657 related articles for article (PubMed ID: 29895255)
1. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
2. Microbiome and hypertension: where are we now?
Vallianou NG; Geladari E; Kounatidis D
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
4. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
6. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Hatton G; Shawcross DL
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
[No Abstract] [Full Text] [Related]
7. The gut microbiota and blood pressure in experimental models.
Jama HA; Kaye DM; Marques FZ
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
Qi Y; Kim S; Richards EM; Raizada MK; Pepine CJ
Circ Res; 2017 May; 120(11):1724-1726. PubMed ID: 28546357
[TBL] [Abstract][Full Text] [Related]
10. Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension.
Sharma RK; Yang T; Oliveira AC; Lobaton GO; Aquino V; Kim S; Richards EM; Pepine CJ; Sumners C; Raizada MK
Circ Res; 2019 Mar; 124(5):727-736. PubMed ID: 30612527
[TBL] [Abstract][Full Text] [Related]
11. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
12. Microbiome and osteoarthritis: New insights from animal and human studies.
Tan TC; Chong TKY; Low AHL; Leung YY
Int J Rheum Dis; 2021 Aug; 24(8):984-1003. PubMed ID: 33961348
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of the preterm gut microbiome in health and disease.
Cuna A; Morowitz MJ; Ahmed I; Umar S; Sampath V
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G411-G419. PubMed ID: 33439103
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
15. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
16. A cross-talk between gut microbiome, salt and hypertension.
Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
[TBL] [Abstract][Full Text] [Related]
17. Role of the normal gut microbiota.
Jandhyala SM; Talukdar R; Subramanyam C; Vuyyuru H; Sasikala M; Nageshwar Reddy D
World J Gastroenterol; 2015 Aug; 21(29):8787-803. PubMed ID: 26269668
[TBL] [Abstract][Full Text] [Related]
18. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
20. The Gut Microbiota in Celiac Disease and probiotics.
Chibbar R; Dieleman LA
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
